NFKB2 and neoplasm: Intriguingly, recent studies showed that the non-canonical, p52/p100 (NF-κB2) pathway is inhibited via proteasomal turnover mediated by F-box protein FBW7, an E3-ubiquitin ligase and tumor suppressor27, 36, 37.